πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,315 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11028083

Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases

The Board of Regents of the University of Texas System Β· Granted Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11021454

Type of aryl benzofuran amidated derivative and medical use thereof

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11008360

Indoleacetic acid derivative and preparation method and pharmaceutical use thereof

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Β· Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10995089

Zaindole derivatives and their use as ERK kinase inhibitors

AGV Discovery Β· Granted Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10995100

Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

Aurigene Discovery Technologies Limited Β· Granted Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10981896

Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase

The Board of Regents of the University of Texas System Β· Granted Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10981866

Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging ag

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10982221

Plant-derived antibodies and derivatives that reduce risk of antibody-dependent enhancemen

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10981855

Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone deri

PTC THERAPEUTICS, INC. Β· Granted Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10973805

Macrocyclic azolopyridine derivatives as EED and PRC2 modulators

Fulcrum Therapeutics, Inc. Β· Granted Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10968166

4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

PTC THERAPEUTICS, INC. Β· Granted Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10968180

Piperidine derivatives as HDAC1/2 inhibitors

Regenacy Pharmaceuticals, Inc. Β· Granted Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10968231

Substituted cyclyl-acetic acid derivatives for the treatment of metabolic disorders

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10968249

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10961205

1,2,4-oxadiazole derivatives as immunomodulators

Aurigene Discovery Technologies Limited Β· Granted Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10954198

Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfoldi

United Kingdom Research and Innovation Β· Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10941128

Thymoquinone derivatives for treatment of cancer

UNITED ARAB EMIRATES UNIVERSITY Β· Granted Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10934274

Quinoline derivatives as TAM RTK inhibitors

Lead Discovery Center GmbH Β· Granted Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10927088

Thymoquinone derivatives for treatment of cancer

UNITED ARAB EMIRATES UNIVERSITY Β· Granted Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10919869

Thiazole derivative and applications

East China University of Science and Technology Β· Granted Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10905683

Compositions and uses of amidine derivatives

BioCryst Pharmaceuticals, Inc. Β· Granted Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10899785

Aminoglycoside derivatives and uses thereof in treating genetic disorders

ELOXX PHARMACEUTICALS LTD. Β· Granted Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10899752

2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10894797

Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors

NIKANG THERAPEUTICS, INC. Β· Granted Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted